Although the majority of head and neck cancers occur between the fifth and sixth decade,
their onset in patients older than 60 years is not a rare event. A peculiar characteristic of …

Abstract Learning Objectives After completing this course, the reader will be able to:
Describe pharmacokinetic changes associated with aging. Describe concepts of geriatric …

Significant mortality is associated with post‐transplant lymphoproliferative disorder (PTLD)
in kidney transplant recipients (KTX). Univariate/multivariate risk factor survival analysis of …

Background The majority of patients with advanced urothelial cancer are elderly, but data
regarding this specific age group are limited. We compared the tolerability and efficacy of …

PURPOSE: We previously demonstrated the efficacy of concurrent gemcitabine, paclitaxel,
and 5-fluorouracil in conjunction with twice-daily (1.5-Gy) radiotherapy delivered on …

As life expectancy increases, surgeons can expect an increasing number of geriatric
patients. In turn, the number of elderly patients presenting with head and neck cancer is …

Persons over the age of 65 are the fastest growing segment of the United States population.
In the next 30 years, they will comprise over 20 percent of the population. Fifty percent of all …

The increasing complexity of cancer chemotherapy heightens the requirement that
pharmacists be familiar with these highly toxic agents. This column will review various …